Engineering Innovation from Concept to Commercialization

Better technology begins with better platforms.

Med-Ally Medical™, a division of QuantumStim™, is an engineering and product development engine dedicated to advancing innovative therapeutic medical technologies. Through a Patent to Patient™ (P2P™)  approach, Med-Ally Medical™ supports every stage of Class II & III medical device development thru commercialization

Engineering with Purpose.

Med-Ally Medical™ brings together engineering, product development, regulatory support, manufacturing and program acceleration by leveraging its clinically proven Neuromodulation platform technologies, VersaStim®. By integrating these capabilities, Med-Ally Medical™ maintains the highest standards of quality, compliance, and patient safety.


Design and Development

Quality & Certification

Operating under FDA 21 CFR Part 820 regulations and an ISO 13485:2016-certified quality management system to deliver safe, reliable, and effective medical devices.

Quality and certification

Risk Management

Guided by ISO 14971, Med-Ally Medical™ integrates comprehensive risk management throughout development to help ensure every device is designed with patient safety at its core.

Risk management

Design & Development

Driven by innovation, Med-Ally Medical™ designs and develops Active Implantable Medical Devices and their supporting components to meet the unique needs of every application.

Innovation in Action

Med-Ally Medical™ platform technologies supports development initiatives clinically driven by QuantumStim Inc. and Physician partners, demonstrating its application across next-generation medical technologies.

NeuroFuse ULE

NeuroFuse® DRG ULE™ represents the application of Med-Ally Medical™ platform technology to targeted dorsal root ganglion (DRG) neuromodulation utilizing ULE™ (Ultra Low Energy™) technology. Developed by SynerFuse®, the NeuroFuse® System is advancing clinical development to provide precise, integrated neuromodulation solutions for chronic neuropathic pain.

OmniPNS ULE

OmniPNS ULE™ (Ultra Low Energy™) represents the application of Med-Ally Medical™ platform technology to next-generation External Pulse Generator (EPG) solutions for peripheral nerve stimulation. QuantumStim™ is currently pursuing FDA 510(k) clearance for OmniPNS ULE™.

Med–Ally MEdical™ Powered by QuantumStim™

Every company within QuantumStim™ plays a unique role in advancing medical technology.

LEADERSHIP

Justin Zenanko 
Chief Executive Officer  

Justin Zenanko is the Founder and Chief Executive Officer of SynerFuse® and provides strategic leadership for Med-Ally Medical™. He oversees the company's long-term vision, commercialization strategy, and platform development, helping advance innovative medical technologies from concept to market. As a co-inventor of the SynerFuse® technology platform, Justin brings extensive experience in entrepreneurship, corporate finance, and medical device innovation. 

Raja Hitti
Chief Technology Officer

Founder

Raja Hitti is the Founder and Chief Technology Officer of Med-Ally Medical™. With more than 30 years of experience in medical device engineering, manufacturing, and product development, he leads the design and advancement of the Med-Ally Medical™ platform technologies. His expertise spans active implantable medical devices, precision manufacturing, quality systems, and commercialization, helping transform innovative concepts into scalable medical technologies. 

Nameer Haider, MD
Chief Innovation Officer

Dr. Nameer Haider serves as Chief Innovation Officer, providing clinical leadership that helps guide the development of the Med-Ally Medical™ engineering and platform technologies. An internationally recognized interventional pain specialist with more than 20 years of experience, he works closely with engineering teams to ensure new technologies are designed with physicians and patients at the center of every innovation. 

Partner With Med-Ally Medical™

Med-Ally Medical™ provides the expertise and infrastructure to accelerate innovation. 

Contact us to: 

  • Learn about our engineering platform  

  • Explore manufacturing capabilities  

  • Discuss product development opportunities  

  • Connect with our engineering team